Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 68, Issue 9, 1994, Pages 6103-6110

  Borrow, Persephone ^a   Lewicki, Hanna ^a   Hahn, Beatrice H ^b   Shaw, George M ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160;

CASE REPORT; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NOTE; PRIORITY JOURNAL; VIREMIA; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0028041344     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.9.6103-6110.1994     Document Type: Note

References (48)

1. Ariyoshi, K., E. Harwood, R. Cheingsong-Popov, and J. Weber. 1992. Is clearance of HIV-1 viremia at seroconversion mediated by neutralizing antibodies? Lancet 340:1257-1258.
2. Auger, I., P. Thomas, and V. DeGruttola. 1988. Incubation periods for pediatric AIDS patients. Nature (London) 336:575-577.
3. Borrow, P., and M. B. A. Oldstone. Immunological aspects of infectious disease: viral diseases, ch. 77. In M. M. Frank, K. F. Austen, H. N. Claman, and E. R. Unanue (ed.), Samter's immunological diseases, 5th ed., in press. Little, Brown & Co., Boston.
4. Byrne, J. A., and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682-686.
5. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
6. Cheingsong-Popov, R., C. Panagiotidi, S. Bowcock, A. Aronstam, J. Wadsworth, and J. Weber. 1991. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. Br. Med. J. 302:23-26.
7. Clark, S. J., M, S. Saag, W. D. Decker, S. Campbell-Hill, J. L. Roberson, P. J. Veldkamp, J. C. Kappes, B. H. Hahn, and G. M. Shaw. 1991. High titres of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
8. Claverie, J. M., P. Kourilsky, D. P. Langlade, P. A. Chalufour, G. Dadaglio, F. Tekaia, F. Plata, and L. Bougueleret. 1988. T-immunogenic peptides are constituted of rare sequence patterns. Use in identification of T epitopes in the human immunodeficiency virus gag protein. Eur. J. Immunol. 18:1547-1553.
9. Clerici, M., J. A. Berzofsky, G. M. Shearer, and C. O. Tacket. 1991. Exposure to human immunodeficiency virus type 1: specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies. J. Infect. Dis. 164:178-182.
10. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012-1019.
11. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary immunodeficiency virus type 1 infection. N. Engl. J. Med. 324:961-964.
12. Earl, P. L., A. W. Hügin, and B. Moss. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J. Virol. 64:2448-2451.
13. Earl, P. L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
14. Falkner, F. G., T. R. Fuerst, and B. Moss. 1988. Use of vaccinia virus vectors to study the synthesis, intracellular localization and action of the human immunodeficiency virus trans-activator protein. Virology 164:450-457.
15. Flexner, C., S. S. Broyles, P. Earl, S. Chakrabarti, and B. Moss. 1988. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology 166:339-349.
16. Hoffenbach, A., P. Langlade-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452-462.
17. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961-971.
18. Johnson, R. P., and B. D. Walker. Cytotoxic T lymphocytes in HIV infection: responses to structural proteins. Curr. Top. Microbiol. Immunol., in press.
19. + T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J. Virol. 64:3399-3406.
20. Karacostas, V., K. Nagashima, M. A. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8967.
21. Koenig, S., P. Earl, D. Powell, G. Pantaleo, S. Merli, B. Moss, and A. S. Fauci. 1988. Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus I (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc. Natl. Acad. Sci. USA 85:8638-8642.
22. Koenig, S., T. R. Fuerst, L. V. Wood, R. M. Woods, J. A. Suzich, G. M. Jones, V. F. Delacruz, R. T. Davey, S. Venkatesan, B. Moss, W. E. Biddison, and A. S. Fauci. 1990. Mapping the fine specificity of a cytolytic T cell response to HIV-1 Nef protein. J. Immunol. 145:127-135.
23. Koup, R. A., J. L. Sullivan, P. H. Levine, D. Brettler, A. Mahr, G. Mazzara, S. McKenzie, and D. Panicali. 1989. Detection of major histocompatibility complex class-I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 73:1909-1914.
24. + cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type I gag. J. Virol. 65:4051-4056.
25. McChesney, M., F. Tanneau, A. Regnault, P. Sansonetti, L. Montagnier, M. P. Kieny, and Y. Riviere. 1990. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur. J. Immunol. 20:215-220.
26. McMichael, A. J., F. M. Gotch, G. R. Noble, and P. A. S. Beare. 1983. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:13-17.
27. Merson, M. H. 1993. Slowing the spread of HIV: agenda for the 1990s. Science 260:1266-1268.
28. Mims, C. A., and D. O. White. 1984. Viral pathogenesis and immunology. Blackwell Scientific Publications, Oxford.
29. Mosier, D. E., R. J. Gulizia, P. D. MacIsaac, L. Corey, and P. D. Greenberg. 1993. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl. Acad. Sci. USA 90:2443-2447.
30. Nixon, D. F., and A. J. McMichael. 1991. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5:1049-1059.
31. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (London) 354:453-459.
32. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
33. Plata, F., B. Autran, L. P. Martins, H. S. Wain, M. Raphael, C. Mayaud, M. Denis, J. M. Guillon, and P. Debre. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (London) 328:348-351.
34. Quinnan, G. V., N. Kirmani, A. H. Rook, J. V. Manishevitz, L. Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. H. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection. N. Engl. J. Med. 307:7-13.
35. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
36. Riviere, Y., F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M.-P. Kieny, J.-J. Fournel, and L. Montagnier. 1989. Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63:2270-2277.
37. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
38. Sethi, K. K., Y. Omata, and K. E. Schnewer. 1983. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of virus-specific and H-2 restricted cytotoxic T lymphocytes. J. Gen. Virol. 64:443-447.
39. Shaw, G. M., and B. H. Hahn. Unpublished data.
40. Tsubota, H., C. I. Lord, D. I. Watkins, C. Morimoto, and N. L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
41. + effector cells armed in vivo with cytophilic antibody. J. Immunol. 142:1177-1182.
42. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 328:345-348.
43. Walker, B. D., C. Flexner, L. K. Birch, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514-9518.
44. Walker, B. D., and F. Plata. 1990. Cytotoxic T lymphocytes against HIV. AIDS 4:177-184.
45. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
46. Whitton, J. L., and M. B. A. Oldstone. 1990. Virus-induced immune response interactions. Principles of immunity and immunopathology, p. 369-381. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, Ltd., New York.
47. Yap, K. L., G. L. Ada, and I. F. C. McKenzie. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (London) 273:238-239.
48. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.